Trial
NCT00523042
Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Novo Nordisk A/S
Collaborators
—
Condition
Diabetes
Intervention
insulin aspart
Why stopped
See termination reason in detailed description
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-05